High Intratumoral PROS1 Expression Correlates with Improved Survival and Is Associated with Suppressed Oncogenic Signaling in Pancreatic Ductal Adenocarcinoma
International Journal of Molecular Sciences · 25.03.2026 · 27 (7) · 2964
DOI: 10.3390/ijms27072964 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.03.2026. Verfasst von Teagan Prouse und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Signal Transduction, Protein S. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Louisiana State University Health Sciences Center New Orleans, LSU-LCMC Cancer Center.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with a five-year survival rate of approximately 13%. Patients with PDAC also have an elevated incidence of venous thromboembolism (VTE), despite prophylactic anticoagulation. Thus, there is an urgent need for therapeutic strategies that target tumor progression and hypercoagulability. Protein S (PS), a physiological anticoagulant encoded by the PROS1 gene, has recently been shown to inhibit PDAC growth in preclinical models. To further examine the physiological relevance of intratumoral PS in PDAC, we performed a meta-analysis of four independent PDAC patient cohorts obtained from cBioPortal. Patients were stratified based on low versus high intratumoral PROS1 expression based on below- and above-average mean expression, overall survival, and gene expression of select pro-growth genes, implementing a fixed-effects model. High intratumoral PROS1 expression was associated with a 41.8% reduction in the risk of death compared with low PROS1 expression (pooled hazard ratio = 0.581) within 30 months of diagnosis from survival data in three cohorts. Elevated PROS1 expression correlated with marked downregulation of key genes implicated in PDAC invasion and metastasis, including MMP2 and SNAI2, in all four cohorts. Collectively, these findings suggest that PROS1 is a potential prognostic biomarker and molecular regulator in PDAC and thus support further investigation into the dual role of PS in tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
- Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
ORCID-Profile: Teagan Prouse, Rinku Majumder, Samarpan Majumder
Förderung
- Louisiana State University Health Sciences Center New Orleans
- LSU-LCMC Cancer Center
Zitieren
APA
Prouse, T., Majumder, R., & Majumder, S. (2026). High Intratumoral PROS1 Expression Correlates with Improved Survival and Is Associated with Suppressed Oncogenic Signaling in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences, 27(7), 2964. https://doi.org/10.3390/ijms27072964
Vancouver
Prouse T, Majumder R, Majumder S. High Intratumoral PROS1 Expression Correlates with Improved Survival and Is Associated with Suppressed Oncogenic Signaling in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences. 2026;27(7):2964. doi:10.3390/ijms27072964
BibTeX
@article{Prouse2026,
author = {Prouse, Teagan and Majumder, Rinku and Majumder, Samarpan},
title = {High Intratumoral PROS1 Expression Correlates with Improved Survival and Is Associated with Suppressed Oncogenic Signaling in Pancreatic Ductal Adenocarcinoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {2964},
doi = {10.3390/ijms27072964}
}
EUVIMED